Preoperative imatinib for patients with primary unresectable or metastatic/recurrent gastrointestinal stromal tumor

OBJECTIVES: Despite its rising popularity, reports on the use of preoperative imatinib mesylate (IM) in patients with advanced gastrointestinal stromal tumor (GIST) are limited. This study aims to explore the clinical efficacy of preoperative IM in patients with primarily unresectable or metastatic/...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Chaoyong, Chen, Haining, Yin, Yuan, Chen, Jiaju, Zhang, Bo, Chen, Zhixin, Chen, Jiaping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2014
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4255202/
https://www.ncbi.nlm.nih.gov/pubmed/25518034
http://dx.doi.org/10.6061/clinics/2014(11)09

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4255202/
https://www.ncbi.nlm.nih.gov/pubmed/25518034
http://dx.doi.org/10.6061/clinics/2014(11)09

Ejemplares similares